Please wait a minute...
Frontiers of Materials Science

ISSN 2095-025X

ISSN 2095-0268(Online)

CN 11-5985/TB

Postal Subscription Code 80-974

2018 Impact Factor: 1.701

Front. Mater. Sci.    2016, Vol. 10 Issue (4) : 346-357    https://doi.org/10.1007/s11706-016-0359-3
RESEARCH ARTICLE
The comparison of the Wnt signaling pathway inhibitor delivered electrospun nanoyarn fabricated with two methods for the application of urethroplasty
Xuran GUO1,Kaile ZHANG2,Mohamed EL-AASSAR1,3,Nanping WANG4,Hany EL-HAMSHARY5,6,Mohamed EL-NEWEHY5,6,Qiang FU2(),Xiumei MO1,7()
1. State Key Lab for Modification of Chemical Fibers & Polymer Materials, College of Chemistry & Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China
2. Department of Urology, Affiliated Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai 200030, China
3. Polymer Materials Research Department, Advanced Technology and New Material Institute, City?of?Scientific?Research?and?Technological?Applications?(SRTA-City),?New?Borg?El-Arab?City, Alexandria 21934,?Egypt
4. Shanghai Aquatic Product Research Institute,?Shanghai 200030,?China
5. Department of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
6. Department of Chemistry, Faculty of Science,?Tanta?University,?Tanta?31527,?Egypt
7. Shandong International Biotechnology Park Development Co., Ltd.,?Shanghai 200030,?China
 Download: PDF(610 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Urethral strictures were common disease caused by over-expression of extracellular matrix from fibroblast. In this study, we compare two nanoyarn scaffolds for improving fibroblasts infiltration without inhibition the?over-expression of extracellular matrix. Collagen/poly(L-lactide-co-caprolactone)?(Col/P(LLA-CL)) nanoyarn scaffolds were prepared by conjugated electrospinning and dynamic liquid electrospinning, respectively. In addition, co-axial electrospinning technique was combined with the nanoyarn fabrication process to produce nanoyarn scaffolds loading?Wnt?signaling pathway inhibitor. The mechanical properties of the scaffolds were examined and morphology was observed by SEM. Cell morphology, proliferation and infiltration on the scaffolds were investigated by SEM, MTT assay and H&E staining, respectively. The release profiles?of different scaffolds were?determined using?HPLC. The results indicated that cells showed an organized morphology along the?nanoyarns and considerable infiltration?into the nanoyarn scaffolds prepared by dynamic liquid electrospinning (DLY). It was also observed that the DLY significantly facilitate cell proliferation. The D-DLY could facilitate the infiltration of the fibroblasts and could be a promising scaffold for the treatment of urethra stricture while it may inhibit the collagen production.

Keywords biomaterials      nanoyarn      electrospinning      inhibitor     
Corresponding Author(s): Qiang FU,Xiumei MO   
Online First Date: 14 November 2016    Issue Date: 24 November 2016
 Cite this article:   
Xuran GUO,Kaile ZHANG,Mohamed EL-AASSAR, et al. The comparison of the Wnt signaling pathway inhibitor delivered electrospun nanoyarn fabricated with two methods for the application of urethroplasty[J]. Front. Mater. Sci., 2016, 10(4): 346-357.
 URL:  
https://academic.hep.com.cn/foms/EN/10.1007/s11706-016-0359-3
https://academic.hep.com.cn/foms/EN/Y2016/V10/I4/346
Fig.1  The chemical structure of ICG-001.
Fig.2  The schematic diagrams of (a) the fabrication of nanoyarn with the dynamic liquid system and (b) the co-axial electrospinning device.
Fig.3  The schematic diagram of the conjugated electrospinning.
Fig.4  SEM images and characteristics of different scaffolds, and their fiber diameter distributions of scaffolds: (a) CY; (b) DLY; (c) NF; (d) D-CY; (e) D-DLY; (f) D-NF.
Fig.5  The TEM image of electrospun Col/P(LLA-CL) loading ICG-001. Red arrows indicate ICG-001.
Fig.6  Mechanical properties of different scaffolds (* p<0.05; ** p<0.01): (a) tensile stress–strain curves; (b) tensile strength at break; (c) strain at break.
Fig.7  The porosity and the pore diameter of different scaffolds.
Fig.8  The images of water droplets on the surface of different scaffolds and water contact angle values.
Fig.9  The cumulative release of the ICG-001 delivered in different scaffolds in 8 weeks in vitro.
Fig.10  (a) The gross morphology and (b) the immunofluorescence of fibroblasts stained with vimentin antibody.
Fig.11  SEM images of cells on scaffolds on day 7 after culture: (a) D-DLY, (d) DLY, (b) D-CY, (e) CY, (c) D-NF and (f) NF.
Fig.12  The relative absorption of MTT assay for fibroblast cells on different scaffolds (DLY, D-DLY, CY, D-CY, NF and D-NF) and cover slips for control on 1, 3, 5, 7 d.
Fig.13  The immunofluorescence of collagen type 1 expression from fibroblasts: (a) fibroblasts without treatment; (b) fibroblasts treated with released medium from D-DLY; (c) fibroblasts treated with released medium from D-CY; (d) fibroblasts treated with released medium from D-NF.
Fig.14  The infiltration of cells in the scaffolds. Cells seeded (a)(c) CY and (b)(d) D-CY at 2 and 3 weeks with different magnification. Cells seeded (e)(g) DLY and (f)(h) D-DLY at 2 and 3 weeks with different magnification.
Fig.1  Fig. S1&chsp;The H&E staining image of fibroblast seeded on nanofiber scaffold (NF).
1 van der Veer W M, Bloemen M C, Ulrich M M, . Potential cellular and molecular causes of hypertrophic scar formation. Burns, 2009, 35(1): 15–29
https://doi.org/10.1016/j.burns.2008.06.020
2 Zhang H, Ran X, Hu C L, . Therapeutic effects of liposome-enveloped Ligusticum chuanxiong essential oil on hypertrophic scars in the rabbit ear model. PLoS One, 2012, 7(2): e31157
https://doi.org/10.1371/journal.pone.0031157
3 Zhang K, Guo X, Zhao W, . Application of Wnt pathway inhibitor delivering scaffold for inhibiting fibrosis in urethra strictures: in vitro and in vivo study. International Journal of Molecular Sciences, 2015, 16(11): 27659–27676
https://doi.org/10.3390/ijms161126050
4 Qi L, Song W, Liu Z, . Wnt3a promotes the vasculogenic mimicry formation of colon cancer via Wnt/β-catenin signaling. International Journal of Molecular Sciences, 2015, 16(8): 18564–18579
https://doi.org/10.3390/ijms160818564
5 Tan J, Tong B-D, Wu Y-J, . MicroRNA-29 mediates TGFβ1-induced extracellular matrix synthesis by targeting wnt/β-catenin pathway in human orbital fibroblasts. International Journal of Clinical and Experimental Pathology, 2014, 7(11): 7571–7577
6 Baarsma H A, Spanjer A I, Haitsma G, . Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β1 is increased in chronic obstructive pulmonary disease. PLoS One, 2011, 6(9): e25450
https://doi.org/10.1371/journal.pone.0025450
7 Bergmann C, Akhmetshina A, Dees C, . Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Annals of the Rheumatic Diseases, 2011, 70(12): 2191–2198
https://doi.org/10.1136/ard.2010.147140
8 Conidi A, van den Berghe V, Huylebroeck D. Aptamers and their potential to selectively target aspects of EGF, Wnt/β-catenin and TGFβ-smad family signaling. International Journal of Molecular Sciences, 2013, 14(4): 6690–6719
https://doi.org/10.3390/ijms14046690
9 Park K, Lee K, Zhang B, . Identification of a novel inhibitor of the canonical Wnt pathway. Molecular and Cellular Biology, 2011, 31(14): 3038–3051
https://doi.org/10.1128/MCB.01211-10
10 Beyer C, Reichert H, Akan H, . Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Annals of the Rheumatic Diseases, 2013, 72(7): 1255–1258
https://doi.org/10.1136/annrheumdis-2012-202544
11 Chuang P Y, Menon M C, He J C. Molecular targets for treatment of kidney fibrosis. Journal of Molecular Medicine, 2013, 91(5): 549–559
https://doi.org/10.1007/s00109-012-0983-z
12 Hao S, He W, Li Y, . Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. Journal of the American Society of Nephrology, 2011, 22(9): 1642–1653
https://doi.org/10.1681/ASN.2010101079
13 Langer R, Vacanti J P. Tissue engineering. Science, 1993, 260(5110): 920–926
https://doi.org/10.1126/science.8493529
14 Zhang Y, Venugopal J R, El-Turki A, . Electrospun biomimetic nanocomposite nanofibers of hydroxyapatite/chitosan for bone tissue engineering. Biomaterials, 2008, 29(32): 4314–4322
https://doi.org/10.1016/j.biomaterials.2008.07.038
15 Wu J, Liu S, He L, . Electrospun nanoyarn scaffold and its application in tissue engineering. Materials Letters, 2012, 89: 146–149
https://doi.org/10.1016/j.matlet.2012.08.141
16 Xu Y, Wu J, Wang H, . Fabrication of electrospun poly(L-lactide-co-ε-caprolactone)/collagen nanoyarn network as a novel, three-dimensional, macroporous, aligned scaffold for tendon tissue engineering. Tissue Engineering Part C: Methods, 2013, 19(12): 925–936
https://doi.org/10.1089/ten.tec.2012.0328
17 Di Lullo G A, Sweeney S M, Korkko J, . Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. The Journal of Biological Chemistry, 2002, 277(6): 4223–4231
https://doi.org/10.1074/jbc.M110709200
18 Kim B S, Mooney D J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends in Biotechnology, 1998, 16(5): 224–230
https://doi.org/10.1016/S0167-7799(98)01191-3
19 Baker B M, Handorf A M, Ionescu L C, . New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Review of Medical Devices, 2009, 6(5): 515–532
https://doi.org/10.1586/erd.09.39
20 Huang C, Chen R, Ke Q, . Electrospun collagen-chitosan-TPU nanofibrous scaffolds for tissue engineered tubular grafts. Colloids and Surfaces B: Biointerfaces, 2011, 82(2): 307–315
https://doi.org/10.1016/j.colsurfb.2010.09.002
21 Grover C N, Cameron R E, Best S M. Investigating the morphological, mechanical and degradation properties of scaffolds comprising collagen, gelatin and elastin for use in soft tissue engineering. Journal of the Mechanical Behavior of Biomedical Materials, 2012, 10: 62–74
https://doi.org/10.1016/j.jmbbm.2012.02.028
22 Ji W, Sun Y, Yang F, . Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharmaceutical Research, 2011, 28(6): 1259–1272
https://doi.org/10.1007/s11095-010-0320-6
23 Mirdailami O, Soleimani M, Dinarvand R, . Controlled release of rhEGF and rhbFGF from electrospun scaffolds for skin regeneration. Journal of Biomedical Materials Research Part A, 2015, 103(10): 3374–3385
https://doi.org/10.1002/jbm.a.35479
24 Baker B M, Handorf A M, Ionescu L C, . New directions in nanofibrous scaffolds for soft tissue engineering and regeneration. Expert Review of Medical Devices, 2009, 6(5): 515–532
https://doi.org/10.1586/erd.09.39
25 Lee H J, Lee S J, Uthaman S, . Biomedical applications of magnetically functionalized organic/inorganic hybrid nanofibers. International Journal of Molecular Sciences, 2015, 16(6): 13661–13677
https://doi.org/10.3390/ijms160613661
26 Li X Y, Li Y C, Yu D G, . Fast disintegrating quercetin-loaded drug delivery systems fabricated using coaxial electrospinning. International Journal of Molecular Sciences, 2013, 14(11): 21647–21659
https://doi.org/10.3390/ijms141121647
27 Stout D A. Recent advancements in carbon nanofiber and carbon nanotube applications in drug delivery and tissue engineering. Current Pharmaceutical Design, 2015, 21(15): 2037–2044
https://doi.org/10.2174/1381612821666150302153406
28 Bonkat G, Braissant O, Rieken M, . Comparison of the roll-plate and sonication techniques in the diagnosis of microbial ureteral stent colonisation: results of the first prospective randomised study. World Journal of Urology, 2013, 31(3): 579–584
https://doi.org/10.1007/s00345-012-0963-5
29 Lv Y. Nanofiber-based drug design, delivery and application. Current Pharmaceutical Design, 2015, 21(15): 1918–1919
https://doi.org/10.2174/1381612821666150304164343
[1] Xin PAN, Binbin SUN, Xiumei MO. Electrospun polypyrrole-coated polycaprolactone nanoyarn nerve guidance conduits for nerve tissue engineering[J]. Front. Mater. Sci., 2018, 12(4): 438-446.
[2] Ling-Yu LI, Bin LIU, Rong-Chang ZENG, Shuo-Qi LI, Fen ZHANG, Yu-Hong ZOU, Hongwei (George) JIANG, Xiao-Bo CHEN, Shao-Kang GUAN, Qing-Yun LIU. In vitro corrosion of magnesium alloy AZ31 --- a synergetic influence of glucose and Tris[J]. Front. Mater. Sci., 2018, 12(2): 184-197.
[3] Juan WANG,Binbin SUN,Muhammad Aqeel BHUTTO,Tonghe ZHU,Kui YU,Jiayu BAO,Yosry MORSI,Hany EL-HAMSHARY,Mohamed EL-NEWEHY,Xiumei MO. Fabrication and characterization of Antheraea pernyi silk fibroin-blended P(LLA-CL) nanofibrous scaffolds for peripheral nerve tissue engineering[J]. Front. Mater. Sci., 2017, 11(1): 22-32.
[4] Qilin WEI,Feiyang XU,Xingjian XU,Xue GENG,Lin YE,Aiying ZHANG,Zengguo FENG. The multifunctional wound dressing with core–shell structured fibers prepared by coaxial electrospinning[J]. Front. Mater. Sci., 2016, 10(2): 113-121.
[5] Wei GUO,Li MENG,Hongcai WANG,Guochun YAN,Weimin MAO. Early-stage nucleation of manganese sulfide particle and its processing evolution in Fe--3wt.%Si alloys[J]. Front. Mater. Sci., 2016, 10(1): 66-72.
[6] Jianchao ZHAN,Yosry MORSI,Hany EI-HAMSHARY,Salem S. AL-DEYAB,Xiumei MO. In vitro evaluation of electrospun gelatin–glutaraldehyde nanofibers[J]. Front. Mater. Sci., 2016, 10(1): 90-100.
[7] Chong WANG,Min WANG. Electrospun multifunctional tissue engineering scaffolds[J]. Front. Mater. Sci., 2014, 8(1): 3-19.
[8] Bhaarathi DHURAI, Nachimuthu SARASWATHY, Ramasamy MAHESWARAN, Ponnusamy SETHUPATHI, Palanisamy VANITHA, Sukumar VIGNESHWARAN, Venugopal RAMESHBABU. Electrospinning of curcumin loaded chitosan/poly (lactic acid) nanofilm and evaluation of its medicinal characteristics[J]. Front Mater Sci, 2013, 7(4): 350-361.
[9] Jian-Guang ZHANG, Xiu-Mei MO. Current research on electrospinning of silk fibroin and its blends with natural and synthetic biodegradable polymers[J]. Front Mater Sci, 2013, 7(2): 129-142.
[10] Punuri Jayasekhar BABU, Pragya SHARMA, Mohan Chandra KALITA, Utpal BORA. Green synthesis of biocompatible gold nanoparticles using Fagopyrum esculentum leaf extract[J]. Front Mater Sci, 2011, 5(4): 379-387.
[11] Shun-Feng WANG, Xiao-Hong WANG, Lu GAN, Matthias WIENS, Heinz C. SCHR?DER, Werner E. G. MüLLER. Biosilica-glass formation using enzymes from sponges [silicatein]: Basic aspects and application in biomedicine [bone reconstitution material and osteoporosis][J]. Front Mater Sci, 2011, 5(3): 266-281.
[12] Jia-Cheng GAO, Li-Ying QIAO, Ren-Long XIN, . Effect of Mg 2+ concentration on biocompatibility of pure magnesium[J]. Front. Mater. Sci., 2010, 4(2): 126-131.
[13] Jia-Cheng GAO, Li-Ying QIAO, Ren-Long XIN, . Corrosion and bone response of magnesium implants after surface modification by heat-self-assembled monolayer[J]. Front. Mater. Sci., 2010, 4(2): 120-125.
[14] Xin-Yu YE, Min-Fang CHEN, Chen YOU, De-Bao LIU, . The influence of HF treatment on corrosion resistance and in vitro biocompatibility of Mg-Zn-Zr alloy[J]. Front. Mater. Sci., 2010, 4(2): 132-138.
[15] Xue-Nan GU, Yu-Feng ZHENG, . A review on magnesium alloys as biodegradable materials[J]. Front. Mater. Sci., 2010, 4(2): 111-115.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed